Correlation of cardiac glycoside binding to their receptors and inhibition of (Na + K) -active ATPase. Clinical significance and application possibilities
Erdmann, E.; Schoner, W.
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 80: 1075-1077
1974
ISSN/ISBN: 0070-4067 PMID: 4281574 Document Number: 80704
Document emailed within 1 workday
Related Documents
Monosíková, R.; Breier, A.; Ziegelhöffer, A.; Sima, F. 1991: Comparison of ATP binding in the active sites of (Na+ + K(+)-ATPase, Mg(2+)-ATPase and Ca(2+)-ATPase with low affinity to calcium from cardiac sarcolemma Bratislavske Lekarske Listy 92(3-4): 142-145Möller, R. 1975: Cardiac glycoside-induced inhibition of membrane ATPase as a cause of digitalis intoxication Medizinische Klinik 70(27): 1166-1173
Ochs, H.R.; Bodem, G.; Schlehbusch, H.; Nuppeney, M.; Baur, M.P.; Oberhoffer, G. 1978: The clinical significance of plasma glycoside concentrations in patients with cardiac pacemakers Zeitschrift für Kardiologie 67(2): 109-115
Wallick, E.T.; Lindenmayer, G.E.; Lane, L.K.; Allen, J.C.; Pitts, B.J.; Schwartz, A. 1977: Recent advances in cardiac glycoside-Na+,K+-ATPase interaction Federation Proceedings 36(9): 2214-2218
Widimský, J. 1993: Cardiac hypertrophy in hypertension--clinical significance and possibilities of control Cor et Vasa 35(2): 84-89
Akera, T.; Baskin, S.I.; Tobin, T.; Brody, T.M. 1974: Cardiac glycosides: temporal relationship between the inotropic action and binding to and dissociation from Na+-K+-activated ATPase in vitro Recent Advances in Studies on Cardiac Structure and Metabolism 4: 149-154
Coezy, E.; Borgna, J.L.; Rochefort, H. 1982: Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth Cancer Research 42(1): 317-323
Eguchi, K.; Yonezawa, M.; Ohmoto, H.; Hayase, R.; Sekiba, K. 1984: Urinary polyamine analysis and its clinical significance. I. Analysis by HPLC and its clinical application. B. Clinical application to the fields of obstetrics and gynecology Rinsho Byori. Japanese Journal of Clinical Pathology Spec no 59: 38-49
Jordan, D.; Junge, N.; Schröder, K.; Schulz, K.; Spangenberg, K.; Wüstenberg, P.W. 1975: Standardized prescription glycoside: results of prescription analysis and clinical observations (glycoside intoxication) Zeitschrift für Arztliche Fortbildung 69(19): 1017-1021
Raschack, M.; Haas, H.; Neugebauer, G.; Sipos, J. 1978: Cardiac effects, relative enteral effectiveness and rate of inactivation of the cardiac glycoside meproscillarin Arzneimittel-Forschung 28(3a): 495-502
Erdmann, E. 1978: Quantitative aspects of the specific binding of cardiac glycosides to membrane-bound receptors Fortschritte der Medizin 96(35): 1758
Stokke, M.; Hagelin, E.M.; Poulsson, C.; Patel, R.; Haile, Y.; Brørs, O. 1992: Inhibition by amiloride and quinacrine of specific [3H]nitrendipine binding to rat cardiac membranes Journal of Pharmacology and Experimental Therapeutics 260(3): 1366-1372
McKay, D.B.; Aronstam, R.S.; Schneider, A.S. 1985: Interactions of microtubule-active agents with nicotinic acetylcholine receptors. Relationship to their inhibition of catecholamine secretion by adrenal chromaffin cells Molecular Pharmacology 28(1): 10-16
Yamada, S.; Isogai, M.; Okudaira, H.; Hayashi, E. 1983: Correlation between cholinesterase inhibition and reduction in muscarinic receptors and choline uptake by repeated diisopropylfluorophosphate administration: antagonism by physostigmine and atropine Journal of Pharmacology and Experimental Therapeutics 226(2): 519-525
Chen, C.L.; Sangiah, S.; Patterson, E.; Berlin, K.D.; Garrison, G.L.; Dunn, W.; Nan, Y.; Scherlag, B.J.; Lazzara, R. 1992: Effects of BRB-I-28, a novel antiarrhythmic agent, and its derivatives on cardiac Na+,K(+)-ATPase, Mg(2+)-ATPase activities and contractile force Research Communications in Chemical Pathology and Pharmacology 78(1): 3-16
Fernö, M.; Borg, A. 1985: Antiestrogen binding sites in human breast cancer biopsies. Measurement ligand-specificity and affinity, and correlation to estrogen and progesterone receptors Anticancer Research 5(3): 307-312
Maisch, B.; Schuff-Werner, P.; Berg, P.A.; Kochsiek, K. 1979: Clinical significance of immunopathological findings in patients with post-pericardiotomy syndrome. II. the significance of serum inhibition and rosette inhibitory factors Clinical and Experimental Immunology 38(2): 198-203
Aharony, D.; Catanese, C.A.; Falcone, R.C. 1989: Kinetic and pharmacologic analysis of [3H]leukotriene E4 binding to receptors on guinea pig lung membranes: evidence for selective binding to a subset of leukotriene D4 receptors Journal of Pharmacology and Experimental Therapeutics 248(2): 581-588
Utz, J.; Eckert, R.; Trautwein, W. 1995: Inhibition of L-type calcium currents in guinea pig ventricular myocytes by the kappa-opioid agonist U50488H does not involve binding to opiate receptors Journal of Pharmacology and Experimental Therapeutics 274(2): 627-633
Brobmann, G.F.; Mikosch, H.; Mayer, M. 1976: Glycoside induced intestinal ischemia. Therapeutic possibilities Medizinische Klinik 71(47): 2066-2071